IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
Covered in this story
What has happened since
- Idexx Laboratories is up 7.8% since this was published, 30 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Idexx Laboratories
- Stifel: $512 → $675 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IDXX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Idexx Laboratories →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.